Durgical
EN
Open the app

Dermatofibroma vs dermatofibrosarcoma protuberans

  • Lesion

Dermatofibroma is a common harmless firm bump. Dermatofibrosarcoma protuberans looks similar early on but keeps growing and comes back if not fully removed.

Updated

What it is

Dermatofibroma is a benign, often reactive, fibrohistiocytic nodule, typically on the legs of young and middle-aged adults, sometimes after minor trauma such as an insect bite. Dermatofibrosarcoma protuberans is a low-grade sarcoma of the dermis and subcutis driven by a COL1A1-PDGFB fusion; it infiltrates widely, recurs locally and rarely metastasises.

Dermatofibroma vs DFSP

FeatureDermatofibromaDermatofibrosarcoma protuberans
BehaviourBenignLow-grade sarcoma, local recurrence
SiteLegsTrunk, proximal limbs
DepthDermis, limitedDermis into fat (honeycomb)
PatternHaphazard fascicles, collagen trappingUniform storiform
EpidermisHyperplasia, basal pigmentThinned, uninvolved
MarkersFactor XIIIa positive, CD34 negativeCD34 positive, factor XIIIa negative
GeneticsClonal in some, usually none specificCOL1A1-PDGFB fusion

Clinical notes

  • DFSP needs wide or Mohs excision with clear margins.
  • Dermatofibroma needs no treatment unless the diagnosis is uncertain.

Test yourself

Think of the answer, then tap the question to see it.

Which fusion drives dermatofibrosarcoma protuberans?

COL1A1-PDGFB, from t(17;22), often in a ring chromosome.

Which immunostain separates DFSP from dermatofibroma?

CD34 is positive in DFSP and negative in dermatofibroma (which is factor XIIIa positive).

Why does imatinib work in DFSP?

The fusion produces excess PDGF-B, and imatinib blocks the PDGF receptor tyrosine kinase.

Add to my cards (3)

More Pathology questions →

Elsewhere in DurgiPedia

Connections

← All of general pathology

Educational content on the mechanisms of disease; not a diagnostic or treatment guide and no substitute for a health professional's advice. No doses are given.

Sources: Dermatofibrosarcoma protuberans (MedlinePlus, US National Library of Medicine, 2025).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.